BioSpace News Archive

Nuvera Life Science Consulting, an expert advisor on patient-centric experience strategies for specialty therapeutics, has launched The PURE Report: Neurology 2020

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that it has been granted a patent on its Bio-RFID technology.

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that veteran regulatory expert Myra Rosario Herrle, PhD, RPh, RAC, has joined the executive management team as Vice President, Regulatory Affairs.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory and liver diseases, today announced that its Phase II exploratory NAFLD/NASH study with Namodenoson achieved its efficacy endpoints, while continuing to demonstrate a good safety profile.

Qosina carries a broad selection of in-stock, single-use bioprocessing components. The company provides 3D CAD models and comprehensive technical specifications, such as material safety data sheets, technical data sheets, material certification and compatibility information on most of these products. Qosina is ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certified, reflecting its unwavering commitment to providing high

Fundación MAPFRE, a global nonprofit foundation created by MAPFRE, announced it will donate $2.3 million to support urgent medical and community needs across Massachusetts, as the coronavirus continues to spread.

COLCORONA trial to examine whether colchicine can reduce complications associated with COVID-19, slow disease progression, and save patient lives

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020.

Perspecta Inc., a leading U.S. government services provider, announced that it has received a follow-on task order award to continue work on the Centers for Medicare & Medicaid Services Virtual Data Center Prime contract to host and improve efficiency of Medicare Part A and Part B Common Working File claims processing.

X4 Pharmaceuticals, Inc. today hosted a virtual Analyst Day, A Deep Dive into WHIM Syndrome , the target disease of the company’s Phase 3 candidate